For laboratory research use only. Not for human or veterinary use.

TB-500

What TB-500 is

TB-500 is a synthetic peptide based on the actin-binding region of thymosin beta-4 (Tβ4), a 43-amino-acid protein found in almost every cell type. Analytical work has identified the acetylated 17-23 fragment of Tβ4 (LKKTETQ) as a key component of material sold as TB-500.

Celvive supplies TB-500 as a 10 mg lyophilised powder in a sealed vial, for laboratory research only.

Where TB-500 has been studied

Most of the literature concerns the parent protein, thymosin beta-4, with a smaller body of work on the fragment itself. The main areas are:

  • Cell migration: actin sequestration and motility assays.
  • Wound and corneal repair: dermal and eye injury models.
  • Angiogenesis: endothelial cell and blood-vessel formation studies.
  • Tendon models: rodent Achilles tendon studies, including work alongside BPC-157.

Proposed mechanisms

Thymosin beta-4 binds G-actin and regulates how cells build and reorganise their cytoskeleton, which is linked to cell migration. Goldstein and colleagues reviewed how this actin-sequestering protein also appears in tissue-repair, angiogenesis and inflammation research.

Limits of the evidence on TB-500

Much of the published work uses full-length thymosin beta-4 rather than the short fragment, and nearly all of it is preclinical. TB-500 is not approved as a medicine by the EMA or the FDA, and it appears on anti-doping prohibited lists.

Working with TB-500 in the lab

Lyophilised peptides are normally reconstituted with a sterile diluent before use in an experiment. Bacteriostatic water and 0.6% acetic acid are available in our lab essentials. Storage and stability guidance is in the FAQ, and a batch certificate can be requested on the certificates of analysis page.

TB-500 is often studied alongside BPC-157; both are combined in the BPC-157 + TB-500 blend. A pre-filled TB-500 QuickPen is also available. Browse every compound in Recovery and tissue research.

TB-500 research FAQ

Is TB-500 the same as thymosin beta-4?

No. Thymosin beta-4 is the full 43-amino-acid protein. TB-500 is a synthetic peptide based on its actin-binding region.

How does TB-500 differ from BPC-157?

They are unrelated sequences. BPC-157 comes from a gastric protein, while TB-500 is derived from thymosin beta-4. They are often used in the same tissue-repair models.

What form is it supplied in?

10 mg of lyophilised powder in a sealed vial.

Selected literature

PubMed records selected for relevance to the compound. They describe published research, not outcomes or uses.